To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0146 | 11ß-hsd1 Inhibitor 544 |
Potent inhibitor of both mouse and human 11β-HSD1
More description
|
|
| DCC0145 | 11-oxo-ete |
Cellular antiproliferative agent, inhibiting BrdU incorporation acrossing multiple cell lines with varying potency
More description
|
|
| DCC0144 | 11-deoxy-pgf2a |
Selective activator of TREK-2 channels, stimulating DRG c-fiber nociceptor K2P currents and limiting calcium influx
More description
|
|
| DCC0143 | 10-fthf |
Donor of formyl groups in anabolism used as a substrate in formyltransferase reactions, which is important in purine biosynthesis
More description
|
|
| DCC0142 | 10074-a4 |
Novel Myc-Max-specific inhibitor
More description
|
|
| DCC0141 | 1.16-hexadecanedithiol |
Long chain dithiol for self-assembled monolayers (SAMs) in sensors
More description
|
|
| DCC0140 | 1,4-nhq |
Inhibitor of the Cdc42-PBD interaction, blocking the association of Cdc42 with the PBD
More description
|
|
| DCC0139 | 1,3,6-trihydroxyxanthone |
Anti-androgenic, Antimicrobial, and anticancer agent
More description
|
|
| DCC0138 | 1(r)-(trifluoromethyl)oleyl Alcohol |
Novel potent ferroptosis inhibitor
More description
|
|
| DCC0137 | 0026-59-kk |
Novel inhibitor of the biosynthesis of DNA, RNA and proteins; Antimicrobial agent
More description
|
|
| DCC0136 | 002-04-kk |
Novel inhibitor of the biosynthesis of DNA, RNA and proteins; Antimicrobial agent
More description
|
|
| DCC0135 | [n9a]lvia |
Novel α-Conotoxin LvIA Analogue, highly selectively trgeting α3β2 nicotinic acetylcholine receptors with >2000-fold higher selectivity than LvIA
More description
|
|
| DCC0134 | [d-trp]cj-15208 |
Short-duration κ opioid receptor antagonist with weak KOR agonist activity
More description
|
|
| DCC0133 | [dmt1,5]n/ofq(1-13)-nh2 |
Novel highly potent dual NOP/mu receptor peptide agonist, exerting antitussive effects in an in vivo model of cough
More description
|
|
| DCC0132 | (z)-5-tetradecen-1-ol |
Novel ligand of the mouse orphan odorant receptor Olfr288
More description
|
|
| DCC0131 | (wrk)5 |
Novel Antimicrobial Peptide with Repeating Unit against Multidrug-Resistant Bacteria
More description
|
|
| DCC0130 | (wrk)4 |
Novel Antimicrobial Peptide with Repeating Unit against Multidrug-Resistant Bacteria
More description
|
|
| DCC0129 | (s)-syaf080 |
Novel Potent Antagonist of the Human A 2B Adenosine Receptor
More description
|
|
| DCC0128 | (s)-syaf030 |
Novel Potent Antagonist of the Human A 2B Adenosine Receptor
More description
|
|
| DCC0127 | (s)-retro-1.1 |
Novel potent inhibitor of Shiga toxin (STX) cytotoxicity
More description
|
|
| DCC0126 | (s)-pomalidomide |
Inhibitor of angiogenesis and growth of B-cell neoplasias, inducing complete regressions of Burkitt's lymphoma cell tumors
More description
|
|
| DCC0125 | (s)-ncc122 |
Potent D1 dopamine ligand
More description
|
|
| DCC0124 | (s)-nbp |
More active enantiomer of NBP; Neuroprotective agent used clinically in the acute phase of ischemic stroke, improving functional recovery and promoting angiogenesis and collateral vessel circulation
More description
|
|
| DCC0123 | (s)-gyramide A |
Novel bacterial DNA gyrase inhibitor, exhibiting antimicrobial activity and inhibiting bacterial cell division
More description
|
|
| DCC0122 | (s)-fty720 Vinylphosphonate |
Novel allosteric Sphingosine kinase 1 (SK1) inhibitor
More description
|
|
| DCC0121 | (s)-ftopm |
mGlu5 PAM, displaying intrinsic agonist activity
More description
|
|
| DCC0120 | (s)-fpopm |
Selective mGlu5 positive allosteric modulator (PAM)
More description
|
|
| DCC0119 | (s)-folcisteine |
S-Enantiomer of folcisteine, a plant growth regulator
More description
|
|
| DCC0118 | (s)-esba Hydrochloride |
Selective kynurenine aminotransferase 2 (KAT2) inhibitor
More description
|
|
| DCC0117 | (s)-desmethyl-nnc112 |
PET precursor for NNC112
More description
|
|
